tirzepatide blindness risk 💉 Optometrists are warning GLP-1 drugs may pose these types of rare risks 💉 ⬇️ Details in comments Tirzepatide vs. Semaglutide: What You

Insurance rarely covers compounded medications

Your dose may need to go up as your body adapts and weight loss plateaus, but your price won'tflat monthly pricing means cost certainty throughout treatment

Fatigue is also reported by some individuals after the injection

Non-fatal myocardial infarction Tirzepatide showed a non-significant trend toward reduction in non-fatal MI compared with placebo (HR 0.83, 95% CI 0.651.05), whereas semaglutide was the only agent that achieved a statistically significant reduction (HR 0.78, 95% CI 0.680.91)

10.1006/geno.1997.5184 54 WangJ

Mean body weight at randomization (Week 20) was 96.1 kg and mean BMI at randomization (Week 20) was 34.4 kg/m 2